Labcorp revenue dips in Q4, increases in fiscal 2021

2021 12 30 00 31 3981 Business Graph Money Stocks 400

Labcorp reported that revenues dipped in its fourth quarter but increased in fiscal year 2021, largely due to a decline in COVID-19 testing during the period. Separately, the company announced a lab management deal with Ascension.

For the fourth quarter (end-December 31), Labcorp's revenue was $4.1 billion, a decrease of 9.7% from $4.5 billion in the fourth quarter of 2020. The dip was mainly due to a decline in organic revenue of 10.3% driven by a decrease in COVID-19 polymerase chain reaction (PCR) and antibody testing, the company said.

For the 2021 full fiscal year, revenue was $16.1 billion, an increase of 15.3% from $13.9 billion in 2020. Net earnings for fiscal year 2021 were $2.38 billion compared to $1.56 billion in 2020, the company reported.

In other news, Labcorp said it has entered an agreement with Ascension, a leading Catholic nonprofit health system, to manage Ascension's hospital-based laboratories in 10 states and purchase select assets of the health system's outreach laboratory business.

The agreement is long-term and will expand Labcorp's clinical laboratory services in several states across the U.S. while creating opportunities to enhance care across all clinical areas, the company said.

Page 1 of 21
Next Page